Moderna (MRNA) and CytomX (CTMX) Enter Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Go back to Moderna (MRNA) and CytomX (CTMX) Enter Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 2.76 -0.06 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.82 | 52 Week High | $24.68 | |||
| Open | $2.83 | 52 Week Low | $9.10 | |||
| Day High | $2.86 | P/E | N/A | |||
| Day Low | $2.72 | EPS | $0.00 | |||
| Volume | 9,597,041 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 154.04 -4.03 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $158.07 | 52 Week High | $0.52 | |||
| Open | $158.35 | 52 Week Low | $0.08 | |||
| Day High | $159.79 | P/E | N/A | |||
| Day Low | $150.29 | EPS | $-3.80 | |||
| Volume | 20,237,194 | |||||
